Clinical Trial Update: Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90

View source ↗

Summary

This clinical trial update indicates a study on using liquid biopsy to characterize hepatocellular carcinoma after Yttrium-90 therapy and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: Palo Alto Veterans Institute for Research | Conditions: Hepatocellular Carcinoma (HCC) | Status: RECRUITING